CHRISTINA A JOHNSTON

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology HOLLAND, MI NPI 1659519296

General Payments — all program years on this page

$2,746.03

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 156
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $558.67 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $558.6721

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $258.9217
ARGENX US, INC. $104.051
Biogen, Inc. $81.731
TG THERAPEUTICS, INC. $80.841
SK Life Science, Inc. $33.131

By program year

Program yearAmountRecords
2018 $424.2519
2019 $279.7418
2020 $111.706
2021 $257.1125
2022 $386.1822
2023 $728.3845
2024 $558.6721

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104004920 ABBVIE INC. $18.61 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104004922 ABBVIE INC. $13.80 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104004924 ABBVIE INC. $11.50 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104004926 ABBVIE INC. $12.64 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104004928 ABBVIE INC. $14.42 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104004930 ABBVIE INC. $12.86 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104004932 ABBVIE INC. $11.50 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104004934 ABBVIE INC. $16.65 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104004936 ABBVIE INC. $6.11 07/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104004938 ABBVIE INC. $14.00 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104004940 ABBVIE INC. $9.66 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104004942 ABBVIE INC. $93.71 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104004944 ABBVIE INC. $6.56 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104004946 ABBVIE INC. $3.19 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104004948 ABBVIE INC. $7.17 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104004950 ABBVIE INC. $3.00 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104004952 ABBVIE INC. $3.54 11/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104821560 Biogen, Inc. $81.73 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136892876 TG Therapeutics, Inc. $80.84 05/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142120857 ARGENX US, INC. $104.05 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154147504 SK Life Science, Inc. $33.13 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.